Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Are there any studies suggesting advil's chemical similarity to antidepressants?Generic tramadol manufacturers?Has lipitor changed wine's appeal in your meals?Which patient groups benefit most from lipitor's ldl lowering?Are there studies on lipitor's interaction with homeopathic medicine?
See the DrugPatentWatch profile for vascepa
Warning Signs of Allergic Reactions to Vascepa and Shellfish Vascepa, an omega-3 fatty acid medication, has been known to cause allergic reactions in some patients [1]. If you're taking Vascepa and have a history of shellfish allergies, it's crucial to be aware of the potential risks. Why Are Shellfish Allergies a Concern with Vascepa? Vascepa's active ingredient, icosapent ethyl, is derived from fish oils. Fish oils are often processed from fish that consume shellfish, such as shrimp, crab, and lobster. These contaminants can trigger allergic reactions in individuals sensitive to shellfish [2]. Symptoms of Allergic Reactions Look out for the following symptoms if you suspect an allergic reaction to Vascepa or shellfish: * Hives or itchy skin * Swelling of face, lips, tongue, or throat * Difficulty breathing * Abdominal cramps * Diarrhea * Vomiting What to Do if You Experience Allergic Reactions If you experience any of these symptoms, seek medical attention immediately. Your healthcare provider may prescribe an antihistamine to alleviate mild symptoms or administer epinephrine in severe cases. Consult Your Healthcare Provider or a Registered Dietitian If you have a history of shellfish allergies, consult your healthcare provider or a registered dietitian before taking Vascepa. They can help you weigh the benefits and risks of this medication and explore alternative treatments. Sources: [1] DrugPatentWatch.com. (2023). icosapent ethyl (Vascepa). https://www.drugpatentwatch.com/patent/icosapent-ethyl-vascepa/ [2] FDA. (2023). Icosapent Ethyl Capsules (Vascepa). https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203822s010lbl.pdf
Other Questions About Vascepa :